Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
9 Meters Biopharma, Inc. (NMTR)
NASDAQ:NMTR
Holding NMTR?
Track your performance easily
See the Price Targets and Ratings of:
NMTR Analyst Ratings
Hold
0 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NMTR Stock 12 Month Forecast
Average Price Target
$0.75
▲(938.78% Upside)
| Highest Price Target$0.75 | Average Price Target$0.75 | Lowest Price Target$0.75 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Brookline Capital Markets
Downgraded
05/25/23
Citi
Reiterated
05/18/23
Maxim Group
Reiterated
05/17/23
Truist Financial
$38
Hold
52531.58%
Upside
Downgraded
03/20/23
9 Meters Biopharma downgraded to Hold from Buy at Truist9 Meters Biopharma downgraded to Hold from Buy at Truist
Roth MKM
$74
Buy
102393.07%
Upside
Reiterated
11/29/22
9 Meters Biopharma trial design increases odds of success, says Brookline9 Meters Biopharma trial design increases odds of success, says Brookline
Raymond James
$35
Buy
48376.45%
Upside
Reiterated
11/10/22
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN), 9 Meters Biopharma (NASDAQ: NMTR) and Graphite Bio (NASDAQ: GRPH)
NMTR Analyst Recommendation Trends
Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
NMTR Financial Forecast
NMTR Stock Forecast FAQ
What is NMTR’s average 12-month price target, according to analysts?
Based on analyst ratings, 9 Meters Biopharma, Inc.’s 12-month average price target is $0.75.
What is NMTR’s upside potential, based on the analysts’ average price target?
9 Meters Biopharma, Inc. has 938.78% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NMTR a Buy, Sell or Hold?
9 Meters Biopharma, Inc. has a consensus rating of Hold which is based on 0 buy ratings, 3 hold ratings and 0 sell ratings.
What is 9 Meters Biopharma, Inc.’s price target?
The average price target for 9 Meters Biopharma, Inc. is $0.75. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $0.75 ,the lowest forecast is $0.75. The average price target represents 938.78% Increase from the current price of <$0.1.
The highest analyst price target is $0.75 ,the lowest forecast is $0.75. The average price target represents 938.78% Increase from the current price of <$0.1.
What do analysts say about 9 Meters Biopharma, Inc.?
9 Meters Biopharma, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of NMTR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.